Advertisement
Screener

Vir Biotechnology, Inc. (VIR) ROE

Vir Biotechnology, Inc. (VIR) ROE

  • 2026-06-30: ROE -25.62%.
  • 2026-03-31: ROE -54.47%.
  • 2025-12-31: ROE -57.23%.
  • 2025-09-30: ROE -62.76%.

Complete source-backed roe history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-25.62%
2026-03-31-54.47%
2025-12-31-57.23%
2025-09-30-62.76%
2025-06-30-58.07%
2025-03-31-55.34%
2024-12-31-45.37%
2024-09-30-42.99%
2024-06-30-33.69%
2024-03-31-34.86%
2023-12-31-38.68%
2023-09-30-35.86%
2023-06-30-14.47%
2023-03-31-7.29%
2022-12-3124.82%
2022-09-3053.15%
2022-06-3055.22%
2022-03-3160.77%
2021-12-3136.92%
2021-09-30-11.68%
2021-06-30-40.33%
2021-03-31-59.96%
2020-12-31-41.66%
2020-09-30-31.61%
2020-06-30-39.11%
2020-03-31-58.70%
2019-12-31-41.20%
2019-09-3048.90%
2019-06-3051.67%

Annual ROE

DateROE
2025-12-31-57.23%
2024-12-31-45.37%
2023-12-31-38.68%
2022-12-3124.82%
2021-12-3136.92%
2020-12-31-41.66%
2019-12-31-41.20%
2018-12-3164.68%
2017-12-31101.36%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Vericel Corp (VCEL)United States$2.011B93.97
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40